An open-label, two period, fixed sequence study of healthy subjects to assess the effect of repeat oral dosing of ketoconazole on the pharmacokinetics of a single oral dose of [GW679769] [casopitant]
Phase of Trial: Phase I
Latest Information Update: 14 Sep 2017
At a glance
- Drugs Casopitant (Primary) ; Ketoconazole
- Indications Chemotherapy-induced nausea and vomiting; Postoperative nausea and vomiting
- Focus Pharmacokinetics
- Sponsors GlaxoSmithKline
- 07 Sep 2007 Status changed from in progress to completed.
- 03 Mar 2007 New trial record.